Catalent, Inc. Price Today
Catalent, Inc.
CTLT
Healthcare
$10.25B
๐ฐ
Market Cap
0
๐ธ
Price to Earnings
$-7.2
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
3 |
Strong Buy |
4 |
Hold |
11 |
Sell |
0 |
Strong Sell |
0 |
CTLT Price Forecast Target
56.7 ๐ 63.5 +12%
CTLT EPS Forecast
-7.2 ๐ 1.5 +-121%
Financials
Profit Margin
-32 %
Revenue Growth
-10.9 %
Dividend
$ 0
Held Percent
0.5% - Insiders
111.3% - Institutions
-11.8% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $1.1B
-
๐ฐ Capital World Investors $1.1B
-
๐ฐ Blackrock Inc. $917.0M
-
๐ฐ Janus Henderson Group PLC $751.1M
-
๐ฐ Nomura Holdings Inc. $651.2M
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investmentโฆJim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency tโฆMichael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM feโฆMichael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across gloโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Catalent, Inc. industry is Drug Manufacturers - Specialty & Generic
The Catalent, Inc. sector is Healthcare
The Catalent, Inc. forecasted predicted Price to Earnings PE ratio is 37.5
The Catalent, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Catalent, Inc. is $10.25B
There are total of 179655056 float shares with 111.3% held by Institutions and 0.5% held by insiders
The MCatalent, Inc. forecasted Earnings per Share EPS is $1.5
The Catalent, Inc. Earnings per Share EPS is -7.2
The Catalent, Inc. company has $0 gross profits with -32 profit margins
The Catalent, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Catalent, Inc. Revenue is $4097999872 with -0.109 revenue growth
The price target for Catalent, Inc. stock is $63.5 for the high target and $42.0 for the low target
The consensus analyst recommendations for Catalent, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Catalent, Inc. is Hold, with the following breakdown:
- Buy: 3
- Strong Buy: 4
- Hold: 11
- Sell: 0
- Strong Sell: 0
The Beta of Catalent, Inc. is 1.2
The dividend of Catalent, Inc. is $0
The dividend yield of Catalent, Inc. is 0%
The biggest institutional and mutual fund holders of Catalent, Inc. stock are
- Vanguard Group Inc
- Capital World Investors
- Blackrock Inc.
- Janus Henderson Group PLC
The Catalent, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0